glp 1 gip dual agonist GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Upcoming wave of hormone-based therapies
Description
Jama 332 , 910 (2024)
Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms
GLP-1RAs attenuate the activation and recruitment of macrophages into the endothelium [63]
168 These studies suggest that diabetes mellitus and a high-fat diet may exacerbate AD inflammation
These trials are mostly based on composite reductions in MACEs (similar to the original ELIXA trial endpoint)
